PF 2391677Alternative Names: PF-2391677
Latest Information Update: 14 May 2009
At a glance
- Originator Pfizer
- Class Digestion aids
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Gastro-oesophageal reflux
Most Recent Events
- 28 Feb 2008 Phase-I clinical trials in Gastro-oesophageal reflux in United Kingdom (unspecified route)